基本信息来源于合作网站,原文需代理用户跳转至来源网站获取       
摘要:
Quinolino[2,1-b]quinazolines 3 and 4, pyrrolo[2,1-b]quinazoline 5 and various substituted 2-(4-chlorostyryl)quinazoline derivatives including: 4-amino derivative 8, 4-hydrazino derivative 9, thiourea derivative 10, thiosemicarbazide derivative 19, 4-benzylidene hydrazinyl derivative 21, 4-amino thiazolidene derivatives 11, 12, 13, 22, imidazoquinazolines 15, 16, quinazolinium chloride 14, triazino[4,3-c]quinazolines 17, 18, tetrazino[1,6-c]quinazoline 20, 4-amino azetidinyl derivative 23, triazolo[4,3-c]quinazoline 24, 4-amino substituted quinazolines 25, 26, 27, 29 and quinazolino quinazoline 28 were synthesized through different chemical reactions. The obtained compounds were evaluated for their in vitro antitumor activity against HEPG2 and MCF-7 cell lines compared to the reference drug (doxorubicin). Compounds 18, 19, 20, 23 and 24 were found to be the most active against both cell lines exhibiting IC50 values ranging from 10.82 - 29.46 μM/L and 7.09 - 31.85 μM/L against Hep-G2 and MCF-7 cell lines, respectively, in addition to docking study of these five compounds against thymidylate synthase and dihydrofolate reductase enzymes active sites.
推荐文章
微波辐射合成7-硝基-4(3H)-喹唑啉酮
7-硝基-4(3H)-喹唑啉酮
微波辐射
正交设计
Isatin Dual Functional Inhibitors:Modulating the Aggregation State and Enzyme Activity of SARS-3CL Proteinase
Isatin derivative
Modulation
SARS-3CL proteinase
Dimerization
Dual functional inhibitor
内容分析
关键词云
关键词热度
相关文献总数  
(/次)
(/年)
文献信息
篇名 Utility of 2-Methyl-quinazolin-4(3H)-one in the Synthesis of Heterocyclic Compounds with Anticancer Activity
来源期刊 药物化学期刊(英文) 学科 化学
关键词 QUINAZOLINE ANTICANCER DHFR TS
年,卷(期) 2014,(1) 所属期刊栏目
研究方向 页码范围 12-37
页数 26页 分类号 O6
字数 语种
DOI
五维指标
传播情况
(/次)
(/年)
引文网络
引文网络
二级参考文献  (0)
共引文献  (0)
参考文献  (0)
节点文献
引证文献  (0)
同被引文献  (0)
二级引证文献  (0)
2014(0)
  • 参考文献(0)
  • 二级参考文献(0)
  • 引证文献(0)
  • 二级引证文献(0)
研究主题发展历程
节点文献
QUINAZOLINE
ANTICANCER
DHFR
TS
研究起点
研究来源
研究分支
研究去脉
引文网络交叉学科
相关学者/机构
期刊影响力
药物化学期刊(英文)
季刊
2164-3121
武汉市江夏区汤逊湖北路38号光谷总部空间
出版文献量(篇)
64
总下载数(次)
0
总被引数(次)
0
论文1v1指导